Home/Filings/4/0001209191-19-043589
4//SEC Filing

HAQUE PROMOD 4

Accession 0001209191-19-043589

CIK 0001636422other

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 9:00 PM ET

Size

32.8 KB

Accession

0001209191-19-043589

Insider Transaction Report

Form 4
Period: 2019-07-29
HAQUE PROMOD
Director10% Owner
Transactions
  • Conversion

    Series F Convertible Preferred Stock

    2019-07-2935,9190 total(indirect: By Partnership)
    Common Stock (35,919 underlying)
  • Conversion

    Common Stock

    2019-07-29+2,952,0912,952,091 total(indirect: By Partnership)
  • Conversion

    Series B Convertible Preferred Stock

    2019-07-291,442,7270 total(indirect: By Partnership)
    Common Stock (1,442,727 underlying)
  • Conversion

    Series E Convertible Preferred Stock

    2019-07-29424,5680 total(indirect: By Partnership)
    Common Stock (424,568 underlying)
  • Conversion

    Common Stock

    2019-07-29+2,952,0902,952,090 total(indirect: By Partnership)
  • Conversion

    Series C Convertible Preferred Stock

    2019-07-29577,0450 total(indirect: By Partnership)
    Common Stock (577,045 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2019-07-29471,8320 total(indirect: By Partnership)
    Common Stock (471,832 underlying)
  • Conversion

    Series E Convertible Preferred Stock

    2019-07-29424,5680 total(indirect: By Partnership)
    Common Stock (424,568 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2019-07-291,442,7270 total(indirect: By Partnership)
    Common Stock (1,442,727 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2019-07-29577,0450 total(indirect: By Partnership)
    Common Stock (577,045 underlying)
  • Conversion

    Series F Convertible Preferred Stock

    2019-07-2935,9190 total(indirect: By Partnership)
    Common Stock (35,919 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2019-07-29471,8310 total(indirect: By Partnership)
    Common Stock (471,831 underlying)
Footnotes (7)
  • [F1]The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.
  • [F2]The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.
  • [F3]The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.
  • [F4]The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.
  • [F5]The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.
  • [F6]The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP ("NVP XI"). By virtue of his position as a Co-Chief Executive Officer of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XI, Promod Haque may be deemed to share voting and dispositive power with respect to such securities. Mr. Haque disclaims beneficial ownership of all such securities, except to the extent of any pecuniary interests therein.
  • [F7]The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP ("NVP XII"). By virtue of his position as a Co-Chief Executive Officer of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XII, Promod Haque may be deemed to share voting and dispositive power with respect to such securities. Mr. Haque disclaims beneficial ownership of all such securities, except to the extent of any pecuniary interests therein.

Issuer

Health Catalyst, Inc.

CIK 0001636422

Entity typeother
IncorporatedCA

Related Parties

1
  • filerCIK 0001089744

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 9:00 PM ET
Size
32.8 KB